Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5376
PUT
iShares MSCI ACWI ETF
ACWI
$33.6B
| $1M | ﹤0.01% |
13,500
-309,900
| -96% | -$22.7M |
|
5377
CALL
Addus HomeCare
ADUS
$2.17B
| $1M | ﹤0.01% |
+14,300
| New | +$926K |
|
5378
First Majestic Silver
AG
$9.49B
| $1M | ﹤0.01% |
+176,513
| New | +$1.09M |
|
5379
CALL
Canadian Imperial Bank of Commerce
CM
$113B
| $1M | ﹤0.01% |
21,400
-30,200
| -59% | -$1.39M |
|
5380
CALL
Travere Therapeutics
TVTX
$5.86B
| $1M | ﹤0.01% |
34,900
+20,500
| +142% | +$586K |
|
5381
CALL
Applied Industrial Technologies
AIT
$13.3B
| $1M | ﹤0.01% |
12,800
-133,000
| -91% | -$10.1M |
|
5382
Cambria Global Momentum ETF
GMOM
$72.6M
| $1M | ﹤0.01% |
37,475
+12,654
| +51% | +$339K |
|
5383
CALL
Mercury Systems
MRCY
$6.67B
| $1M | ﹤0.01% |
18,100
+9,700
| +115% | +$469K |
|
5384
Veracyte
VCYT
$3.32B
| $1M | ﹤0.01% |
+104,741
| New | +$1.16M |
|
|
ONC
5385
BeOne Medicines Ltd
ONC
$39.3B
| $1M | ﹤0.01% |
5,813
-14,765
| -72% | -$2.48M |
|
|
IMPV
5386
DELISTED
Imperva, Inc.
IMPV
| $1M | ﹤0.01% |
21,549
-31,067
| -59% | -$1.5M |
|
|
EMBJ
5387
PUT
Embraer S.A. ADS
EMBJ
$13.4B
| $999K | ﹤0.01% |
51,000
+36,100
| +242% | +$730K |
|
5388
Ultrapar
UGP
$6.56B
| $999K | ﹤0.01% |
+215,760
| New | +$1.15M |
|
5389
UNIFI
UFI
$120M
| $998K | ﹤0.01% |
35,223
-10,941
| -24% | -$342K |
|
5390
CALL
Webster Financial
WBS
$12.8B
| $996K | ﹤0.01% |
16,900
+9,700
| +135% | +$631K |
|
5391
PUT
Heron Therapeutics
HRTX
$63.9M
| $994K | ﹤0.01% |
31,400
-11,200
| -26% | -$417K |
|
|
DBVT
5392
DBV Technologies
DBVT
$881M
| $993K | ﹤0.01% |
4,421
-43,054
| -91% | -$8.75M |
|
5393
Novanta
NOVT
$6.3B
| $993K | ﹤0.01% |
14,520
-6,260
| -30% | -$439K |
|
5394
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.9M
| $992K | ﹤0.01% |
+1,516
| New | +$1.05M |
|
5395
ProShares UltraPro Short QQQ
SQQQ
$1.68B
| $992K | ﹤0.01% |
+36
| New | +$1.1M |
|
|
EFII
5396
DELISTED
Electronics for Imaging
EFII
| $992K | ﹤0.01% |
29,131
+11,017
| +61% | +$374K |
|
5397
Artisan Partners
APAM
$2.99B
| $991K | ﹤0.01% |
30,583
+22,008
| +257% | +$717K |
|
5398
CALL
ProShares Ultra Energy
DIG
$85.6M
| $990K | ﹤0.01% |
18,240
+5,280
| +41% | +$278K |
|
5399
Dorman Products
DORM
$4.05B
| $990K | ﹤0.01% |
12,869
-63,533
| -83% | -$4.86M |
|
5400
PUT
Fabrinet
FN
$20.4B
| $990K | ﹤0.01% |
21,400
+7,600
| +55% | +$327K |
|
Similar funds
Citadel Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Citadel Advisors opened 1,427 new positions and closed 1,043 in Q3 2018.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.